Literature DB >> 1381371

Coexpression of renin, angiotensinogen, and their messenger ribonucleic acids in adrenal tissues.

K Racz1, F Pinet, J M Gasc, T T Guyene, P Corvol.   

Abstract

The presence of the two components of the renin-angiotensin system (RAS) has been systematically investigated in human normal and pathological adrenal tissues with two aims: 1) the detection of renin and especially angiotensinogen, which has not been reported before; and 2) to study possible differences in the coexpression of renin and angiotensinogen in tissue of cortical and medullary origin. The relative levels of renin and angiotensinogen mRNAs were determined by Northern blot analysis in normal (n = 5) and pathological adrenal tissues of cortical (n = 23) and medullary (n = 10) origin. Renin, prorenin, and angiotensinogen levels were also measured. Renin concentrations in normal and pathological adrenals were around 30-fold higher than those in the plasma of normal subjects, except for a Cushing's adenoma, which contains an extremely high renin content. Renin accounted for 56% of the total renin in normal adrenals and up to 87% in neoplastic tissues. This high proportion of renin indicates a likely conversion of prorenin to renin within these tissues. Renin mRNA was detected in each group of adrenal tissues. There was a significant correlation between the concentration of renin and its mRNA (r = 0.75; P less than 0.05). Angiotensinogen and its mRNA were detected in all normal and pathological adrenals. Compared to normal adrenal tissues, the relative amount of angiotensinogen mRNA was significantly higher in pheochromocytomas. However, the increased mRNA level in these tissues was not accompanied by a parallel increase in tissue angiotensinogen levels. Since the translational efficiency of angiotensinogen was verified by in vitro cell-free translation, the low level of angiotensinogen compared to the relatively high amount of its mRNA suggests a lack of storage of this protein in adrenal cells, as in liver cells. This study demonstrates that renin and angiotensinogen are coexpressed in normal and pathological tissues. Tissues of different cellular origin (zona glomerulosa, fasciculata, and medullary tissue), were able to express, store, and process renin and synthesize angiotensinogen. There was no obvious relationship between the expression of these proteins and the pathophysiology of the adrenal gland.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381371     DOI: 10.1210/jcem.75.3.1381371

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor.

Authors:  A R Brasier; M Jamaluddin; Y Han; C Patterson; M S Runge
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

2.  Renin-like immunoreactivity in human placenta and fetal membranes.

Authors:  M Hanssens; L Vercruysse; L Verbist; R Pijnenborg; M J Keirse; F A Van Assche
Journal:  Histochem Cell Biol       Date:  1995-12       Impact factor: 4.304

3.  Exploration of cardiometabolic and developmental significance of angiotensinogen expression by cells expressing the leptin receptor or agouti-related peptide.

Authors:  Sarah A Sapouckey; Lisa L Morselli; Guorui Deng; Chetan N Patil; Kirthikaa Balapattabi; Vanessa Oliveira; Kristin E Claflin; Javier Gomez; Nicole A Pearson; Matthew J Potthoff; Katherine N Gibson-Corley; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-03-18       Impact factor: 3.619

4.  Study of the rat adrenal renin-angiotensin system at a cellular level.

Authors:  C Y Chiou; G H Williams; I Kifor
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

5.  Increased Susceptibility of Mice Lacking Renin-b to Angiotensin II-Induced Organ Damage.

Authors:  Pablo Nakagawa; Anand R Nair; Larry N Agbor; Javier Gomez; Jing Wu; Shao Yang Zhang; Ko-Ting Lu; Donald A Morgan; Kamal Rahmouni; Justin L Grobe; Curt D Sigmund
Journal:  Hypertension       Date:  2020-06-08       Impact factor: 9.897

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.